Eisai - M&A Summary and Business Overview

Life ScienceCompany

Eisai M&A Summary

Eisai has acquired 2 companies, including 1 in the last 5 years. It has also divested 2 assets.

Eisai’s largest acquisition to date was in 2010, when it acquired AkaRx for $255M. It’s largest disclosed sale occurred in 2019, when it sold Eisai - Two Medicines to ADVANZ PHARMA for $33M. Eisai has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

Eisai Business Overview

Where is Eisai headquartered?

Eisai is headquartered in Woodcliff Lake, New Jersey.

What sector is Eisai in?

Eisai is a life science company.

When was Eisai founded?

Eisai was founded in 1995.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity2
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

Eisai, Inc.

100 Tice Boulevard,
Woodcliff Lake, New Jersey 07677
United States,
(201) 692-1100
www.us.eisai.com

Eisai, Inc. is a pharmaceutical company focuses on neurology, gastrointestinal disorders and oncology/critical care.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 1 - - - - 1 2
vol $255M $255M
Sell (0.0/yr) # 2 - - - - - 2
vol $33M $33M
  4

Most Recent M&A

Company Date Value Type
C2N Diagnostics LLC 2024-03-06 - Growth Capital
St. Louis, Missouri · www.c2n.com
Eisai, Inc. - Two Medicines (Salagen & Panretin) 2019-04-01 33M USD Divestiture
Woodcliff Lake, New Jersey
AkaRx, Inc. 2016-03-30 - Divestiture
Paramus, New Jersey
AkaRx, Inc. 2010-01-06 255M USD Add-on Acquisition
Paramus, New Jersey
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 255M (100%) 2 (100%) 33M (100%)
Total 2 $255M 2 $33M

By Geo

State/Country Buy Value Sell Value
United States 2 255M 2 33M
  New Jersey 1 255M 2 33M
  Missouri 1 - - -
Total 2 $255M 2 $33M

Deal Values

buy # Total
$100M to $1B 1 $255M
TOTAL $255M
Largest AkaRx, Inc.
$255M (2010-01-06)
sell # Total
< $100M 1 $33M
TOTAL $33M
Largest Eisai, Inc. - Two Medicines (Salagen & Panretin)
$33M (2019-04-01)

M&A Connections

Deals
Divested to
Investor(s)
50%
1 (50%)
Strategic(s)
50%
1 (50%)

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.